Universidad de Burgos Repositorio Repositorio
Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10259/4994

Ver estadísticas de uso
Título : Insulin degrading enzyme is up-regulated in pancreatic β cells by insulin treatment
Autor : Fernández Díaz, Cristina M. .
Escobar Curbelo, Luis .
López Acosta, J.F. .
Lobatón, Carmen D. .
Moreno, Alfredo .
Sanz Ortega, Julián .
Perdomo Hernández, Germán M.
Cózar Castellano, Irene .
Publicado en: Histology and Histopathology. 2018, V. 33, n. 11, p. 1167-1180
Editorial : Universidad de Murcia
Fecha de publicación : nov-2018
ISSN : 0213-3911
DOI: 10.14670/HH-11-997
Resumen : Insulin Degrading Enzyme (IDE) is an endopeptidase that degrades insulin and glucagon. Ide gene has been associated with type-2 diabetes mellitus (DM2). However, the physiological role(s) of IDE in glucose homeostasis and its potential therapeutic benefit remain not completely known. To contribute in the understanding of IDE's role in glucose metabolism, we analyzed IDE protein level in pancreatic islets from two hyperinsulinemic mouse models, db/db and high-fat diet (HFD) mice, as well as in human islets from DM2 patients treated with oral hypoglycemic agents (OHAs) or insulin. IDE protein level was detected by staining and by western-blot. INS1E cells, rat and human islets were treated with insulin and IDE protein level was studied. We have shown for the first time IDE staining in rodent and human tissue, using the proper negative control, IDE null mouse tissue. Our staining indicates that IDE is expressed in both beta- and alpha-cells, with higher expression in alpha-cells. Db/db and HFD mice islets showed increased IDE protein level. Interestingly, human islets from DM2 patients treated with OHAs showed decreased IDE protein level in beta-cells. Meanwhile, islets from insulin-treated DM2 patients showed augmented IDE protein level compared to OHAs patients, pointing to an upregulation of IDE protein level stimulated by insulin. These data correlate nicely with insulin-stimulated upregulation of IDE in cultured INS1E cells, as well as in rat and human islets.In conclusion, our study shows that IDE is expressed in pancreatic beta- and alpha-cells of both rodents and humans, having higher expression in alpha-cells. Furthermore, insulin stimulates IDE protein level in pancreatic beta-cells. These results may have implications in how DM2 patient’s treatment affects their beta-cell function.
Palabras clave: Insulin-degrading enzyme
Type 2 diabetes,
Insulin treatment,
OHAs
Beta-cells
Alpha-cells
Rodent islets
Human islets
Materia: Endocrinología
Endocrinology
Licencia: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es_ES
URI : http://hdl.handle.net/10259/4994
Versión del editor: http://www.hh.um.es/2018/HH_33_11_2018.htm
Aparece en las colecciones: Artículos DIABO-TER

Ficheros en este ítem:

Fichero Descripción Tamaño Formato
Fernandez-hh_2018.pdf20,82 MBAdobe PDFVisualizar/Abrir

Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons
Creative Commons

Los ítems del Repositorio Institucional de la Universidad de Burgos están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2008 MIT and Hewlett-Packard - Sobre DSpace